Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Dallas TX, Houston TX, San Antonio TX, Saint Louis MO,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05940857
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Dallas TX, Houston TX, San Antonio TX, Little Rock AR,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
for
Relapsed or Refractory Acute Myeloid Leukemia (AML),
Location: Dallas TX, Houston TX, Charleston SC
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT02074839
Phase 1, Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Dallas TX, Chicago IL, Portland OR
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
for
Liver Fibroses, Cirrhosis
Location: Dallas TX, Boston MA
Sponsor: Raymond Chung
Sex: All
Age: 18+
Code: NCT05028829
Phase 2, Recruiting
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Dallas TX, Austin TX, Kansas City KS, Aurora CO,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Dallas TX, Houston TX, Columbus OH, Canton OH,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase 1, Recruiting
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Dallas TX
Sponsor: Secretome Therapeutics
Sex: All
Age: 18+
Code: NCT06560762
Phase 1, Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Dallas TX, Oklahoma City OK, Houston TX, Fairway KS,
Sponsor: Ansun Biopharma, Inc.
Sex: All
Age: 0+
Code: NCT03808922
Phase 3, Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Dallas TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase 1, Phase 2, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
for
Cystic Fibrosis Lung
Location: Dallas TX, Kansas City KS, Birmingham AL, Denver CO,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT05248230
Phase 2, Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer